This can be particularly beneficial for individuals on weight loss programs
Common Side Effects & How to Manage Them Like any medication, GLP-1s come with potential side effects , with the most common being: Nausea Diarrhea or constipation Fatigue & dizziness (often tied to not eating enough ) Because appetite suppression can be extreme, some people accidentally eat too little , leading to fatigue, dizziness, and muscle loss
The adrenal medulla, an extension of the sympathetic nervous system, on the other hand, produces catecholamines such as epinephrine (adrenaline) and norepinephrine (14) ( Figure 1 ), which have widespread impacts on the cardiovascular system, metabolism, and other body systems
Conclusion GLP-1 receptor agonists may well be the right drug at the right time for midlife women: tackling the metabolic storm of menopause, reducing future disease risk, and potentially extending healthspan
Glapp does not distinguish between the active loss period and long-term weight maintenance
Novo Nordisks Wegovy pill, the first weight-loss drug to win approval from the agency, is expected to launch in the US in early 2026